{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-087020","form_type":"8-K","ticker":"BCYC","cik":"0001761612","company_name":"BICYCLE THERAPEUTICS PLC","filed_at":"2023-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.150404+00:00","generated_at":"2026-06-12T08:58:10.905966+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Bicycle Therapeutics Q2 net loss widens to $1.41/sh; cash >$600M after $230M raise","bullets":["Net loss $42.6M ($1.41 loss per share) vs $26.8M ($0.90) a year ago; R&D expense doubled to $39.7M.","Cash $340.4M at June 30, 2023; pro-forma over $600M including $230M July offering and $45M Bayer upfront.","Strategic collaborations with Novartis (up to $1.7B milestones) and Bayer (up to $1.7B) for Bicycle radio-conjugates.","Appointed Alethia Young as CFO effective July 17, 2023; clinical updates on BT8009 expected in 2H23.","Preclinical data for Pb-BCY20603 BRC showed complete tumor regressions in rodent xenograft studies."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-087020","json":"https://secwatch.observer/filing/0001104659-23-087020.json","markdown":"https://secwatch.observer/filing/0001104659-23-087020.md","text":"https://secwatch.observer/filing/0001104659-23-087020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1761612/000110465923087020/0001104659-23-087020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1761612/000110465923087020/tm2322663d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T08:58:10.905966+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}